You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 142 No. 3, March 1982 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  REVIEW ARTICLE
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Down's Syndrome as a Model Disease

Charles H. Scoggin, MD; David Patterson, PhD

Arch Intern Med. 1982;142(3):462-464.


Abstract



Aneuploid chromosomal disorders may offer insight into the pathogenesis of certain common diseases. The birth defects and mental retardation that characterize Down's syndrome are well recognized. In addition, the altered chromosomal content that occurs in the syndrome apparently affects the prevalence of a variety of disorders, such as malignancy, endocrine dysfunction, infection, atherosclerosis, and premature aging. Because the single distinguishing factor in Down's syndrome is the presence of an excess of a part of chromosome 21, the genetic information contained in this chromosomal segment seems to be responsible for the disease manifestations. Techniques of somatic cell genetics and molecular biology allow mapping of human genes and study of their expression. With such methods it should be possible to understand Down's syndrome and other aneuploid disorders and to apply these considerations to other areas of medicine.

(Arch Intern Med 1982;142:462-464)



Author Affiliations



From the Department of Medicine (Pulmonary Sciences), The Eleanor Roosevelt Institute for Cancer Research (Dr Scoggin); Florence Sabin Laboratories for Genetics and Developmental Medicine (Drs Scoggin and Patterson); and the Webb-Waring Lung Institute, University of Colorado Health Sciences Center (Dr Scoggin), Denver.


Footnotes



Accepted for publication April 8, 1981.

Reprint requests to 4200 E Ninth Ave, Box C272, Denver, CO 80262 (Dr Scoggin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Use of a fluorescent-PCR reaction to detect genomic sequence copy number and transcriptional abundance.
Chiang et al.
Genome Res 1996;6:1013-1026.
ABSTRACT  

Molecular Genetics of Down's Syndrome: Overexpression of Transfected Human Cu/Zn-Superoxide Dismutase Gene and the Consequent Physiological Changes
Groner et al.
Cold Spring Harb Symp Quant Biol 1986;51:381-393.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.